Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection

por Jarrard, William E., Schultz, Adam, Etheridge, Tyler, Damodaran, Shivashankar, Allen, Glenn O., Jarrard, David, Yang, Bing
Publicado 2019

Osteopathic Manipulative Medicine: A Brief Review of the Hands-On Treatment Approaches and Their Therapeutic Uses

por Roberts, Ashley, Harris, Kaylee, Outen, Bethany, Bukvic, Amar, Smith, Ben, Schultz, Adam, Bergman, Stephen, Mondal, Debasis
Publicado 2022

Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier

por Etheridge, Tyler, Damodaran, Shivashankar, Schultz, Adam, Richards, Kyle A., Gawdzik, Joseph, Yang, Bing, Cryns, Vincent, Jarrard, David F.
Publicado 2019

Citrate-based fluorometric sensor for multi-halide sensing

por Wang, Dingbowen, Xia, Tunan, Wang, Yuqi, Chen, Yizhu, Zhang, Chenji, Murray, William, Schultz, Adam Thomas, Liu, Zhiwen, Yang, Jian
Publicado 2022

Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsies

por Yang, Bing, Etheridge, Tyler, McCormick, Johnathon, Schultz, Adam, Khemees, Tariq A., Damaschke, Nathan, Leverson, Glen, Woo, Kaitlin, Sonn, Geoffrey A., Klein, Eric A., Fumo, Mike, Huang, Wei, Jarrard, David F.
Publicado 2019